`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`
`FDA Home3 Drug Databases4 Orange Book5
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`Orange Book Search Results on patent number '6743413' in the OB_Rx list.
`
`Appl No
`
`Prod No
`
`Active Ingredient
`
`Patent No
`
`Patent Expire Drug
`Substance
`Claim
`
`Drug Product
`Claim
`
`Patent Use
`Code
`
`Delist
`Requested
`
`6743413*PED Dec 1, 2021
`
`6743413
`
`Jun 1, 2021
`
`6743413*PED Dec 1, 2021
`
`6743413
`
`Jun 1, 2021
`
`6743413*PED Dec 1, 2021
`
`6743413
`
`Jun 1, 2021
`
`6743413*PED Dec 1, 2021
`
`6743413
`
`Jun 1, 2021
`
`6743413*PED Dec 1, 2021
`
`6743413
`
`Jun 1, 2021
`
`U -716
`
`U -581
`
`U -581
`
`U -581
`
`U -1591
`
`U -1591
`
`U -1591
`
`N020983
`N020983
`N021433
`
`N021433
`
`N021433
`
`N021433
`
`N021433
`
`N021433
`
`N021254
`
`001
`001
`001
`
`001
`
`002
`
`002
`
`003
`
`003
`
`001
`
`N021254
`
`001
`
`N021254
`
`002
`
`N021254
`
`002
`
`N021254
`
`003
`
`N021254
`
`003
`
`Jun 1, 2021
`ALBUTEROL SULFATE 6743413
`ALBUTEROL SULFATE 6743413*PED Dec 1, 2021
`FLUTICASONE
`6743413
`Jun 1, 2021
`PROPIONATE
`FLUTICASONE
`PROPIONATE
`FLUTICASONE
`PROPIONATE
`FLUTICASONE
`PROPIONATE
`FLUTICASONE
`PROPIONATE
`FLUTICASONE
`PROPIONATE
`FLUTICASONE
`PROPIONATE;
`SALMETEROL
`XINAFOATE
`FLUTICASONE
`PROPIONATE;
`SALMETEROL
`XINAFOATE
`FLUTICASONE
`PROPIONATE;
`SALMETEROL
`XINAFOATE
`FLUTICASONE
`PROPIONATE;
`SALMETEROL
`XINAFOATE
`FLUTICASONE
`PROPIONATE;
`SALMETEROL
`XINAFOATE
`FLUTICASONE
`PROPIONATE;
`SALMETEROL
`XINAFOATE
`
`6743413*PED Dec 1, 2021
`
`Additional information:
`1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
`2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be
`flagged with respect to other claims which may apply.
`View a list of all patent use codes
`Return to Electronic Orange Book Home Page6
`FDA/Center for Drug Evaluation and Research
`Office of Generic Drugs
`Division of Labeling and Program Support
`Update Frequency:
`Orange Book Data - Monthly
`Generic Drug Product Information & Patent Information - Daily
`Orange Book Data Updated Through November 2015
`Patent and Generic Drug Product Data Last Updated December 24, 2015
`
`Links on this page:
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`2. http://www.addthis.com/bookmark.php
`http://www.accessdata.fda.gov/scripts/cder/ob/docs/newobpat.cfm
`
`1/2
`
`1
`
`3M COMPANY 2006
`Mylan Pharmaceuticals Inc. v. 3M Company
`IPR2015-02002
`
`
`
`12/28/2015
`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`
`3. http://www.fda.gov/default.htm
`4. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`5. ../default.cfm
`6. ../default.cfm
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
`Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency Website Policies
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1-888-INFO-FDA (1-888-463-6332)
`Contact FDA
`
`
`
`
`
`
`
`For Government For Press
`Combination Products Advisory Committees Science & Research Regulatory Information Safety Emergency Preparedness International Programs News &
`Events Training and Continuing Education Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive
`
`
`
`Links on this page:
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`2. http://www.addthis.com/bookmark.php
`3. http://www.fda.gov/default.htm
`4. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`5. ../default.cfm
`6. ../default.cfm
`
`http://www.accessdata.fda.gov/scripts/cder/ob/docs/newobpat.cfm
`
`2/2
`
`2